FDA Approval of Extended-Release Oxycodone for Children with Severe Pain: A Step Forward

被引：0

作者：

Ruan, Xiulu ^{[1
]}

Chiravuri, Srinivas ^{[2
]}

Kaye, Alan D. ^{[1
]}

机构：

[1] Louisiana State Univ, Hlth Sci Ctr, Dept Anesthesiol, New Orleans, LA 70112 USA

[2] Univ Michigan Hlth Syst, Dept Anesthesiol, Back & Pain Ctr, Ann Arbor, MI USA

来源：

PAIN MEDICINE | 2017年 / 18卷 / 06期

关键词：

D O I：

10.1093/pm/pnw257

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

引用

页码：1202 / 1203

页数：3

共 50 条

[21] Duration of use of extended-release oxycodone and morphine among adults with cancer and non-cancer pain
DeVeaugh-Geiss, A.
Kadakia, A.
Chilcoat, H.
Coplan, P.
JOURNAL OF PAIN, 2013, 14 (04): : S75 - S75
[22] Extended-Release Buprenorphine Receives FDA Green Light
Harris, Emily
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (24): : 2119 - 2119
[23] Oxycodone Extended-Release Capsule Utilization for Pain Management in a Cancer Palliative Care Clinic: A Retrospective Review
Fortunato, Jordan
Kullgren, Justin
Houchard, Gary
Hirsch, Jessica
Shirilla, Nicole
Bumb, Meridith
Li, Junan
JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY, 2023, 37 (04) : 286 - 297
[24] Abuse of Extended-Release (ER) and Immediate-Release Oxycodone in Kentucky Following Introduction of Reformulated ER Oxycodone
DeVeaugh-Geiss, A.
Leukefeld, C.
Havens, J.
Coplan, P.
Chilcoat, H.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 447 - 447
[25] Changes after Reformulation of Extended-Release Oxycodone in Calls to US Poison Centers for Oxycodone and Heroin
Coplan, Paul M.
Kale, Hrishikesh
Sandstrom, Lauren
Chilcoat, Howard D.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 241 - 241
[26] Clinical and economic evaluation of tapentadol extended release and oxycodone/naloxone extended release in comparison with controlled release oxycodone in musculoskeletal pain
Coluzzi, Flaminia
Ruggeri, Matteo
CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (06) : 1139 - 1151
[27] A randomized, double-blind study of hydromorphone hydrochloride extended-release tablets versus oxycodone hydrochloride extended-release tablets for cancer pain: efficacy and safety in Japanese cancer patients (EXHEAL: a Phase III study of EXtended-release HydromorphonE for cAncer pain reLief)
Inoue, Satoshi
Saito, Yoji
Tsuneto, Satoru
Aruga, Etsuko
Ide, Azusa
Kakurai, Yasuyuki
JOURNAL OF PAIN RESEARCH, 2017, 10 : 1953 - 1961
[28] The effect of FDA approval of a generic competitor to OxyContin® (oxycodone HCl controlled-release) tablets on the abuse of oxycodone
Bailey, J. Elise
Barton, Phoebe Lindsey
Lezotte, Dennis
Lowenstein, Steven R.
Dart, Richard C.
DRUG AND ALCOHOL DEPENDENCE, 2006, 84 (02) : 182 - 187
[29] Converting from incoming opioids to oxycodone extended-release (OXYCR) tablets or oxycodone/naloxone extended-release (OXN) tablets - an analysis of the experience from 5 controlled clinical trials
Steiner, D.
Moline, M.
Munera, C.
Berger, B.
JOURNAL OF PAIN, 2014, 15 (04): : S89 - S89
[30] Comment and Reply on: Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain
Crudele, Nancy
Haddox, J. David
CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (05) : 1053 - 1054

← 1 2 3 4 5 →